SCHEDULE 13G/A 0001193125-24-015197 0001863769 XXXXXXXX LIVE 1 Common Stock, $0.0001 par value per share 03/31/2025 0001796280 ORIC Pharmaceuticals, Inc. 68622P109 240 E. Grand Ave, 2nd Floor South San Francisco CA 94080 Rule 13d-1(c) Frazier Life Sciences Public Fund, L.P. DE 0.00 605554.00 0.00 605554.00 605554.00 0.9 PN The shares listed in rows 6, 8 and 9 consist of 605,554 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. FHMLSP, L.P. DE 0.00 605554.00 0.00 605554.00 605554.00 0.9 PN The shares listed in rows 6, 8 and 9 consist of 605,554 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. FHMLSP, L.L.C. DE 0.00 605554.00 0.00 605554.00 605554.00 0.9 OO The shares listed in rows 6, 8 and 9 consist of 605,554 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. Frazier Life Sciences Public Overage Fund, L.P. DE 0.00 416494.00 0.00 416494.00 416494.00 0.6 PN The shares listed in rows 6, 8 and 9 consist of 416,494 shares of Common Stock held directly by Frazier Life Sciences Public Overage Fund, L.P. FHMLSP Overage, L.P. is the general partner of Frazier Life Sciences Public Overage Fund, L.P. and FHMLSP Overage, L.L.C. is the general partner of FHMLSP Overage, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP Overage, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Overage Fund, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. FHMLSP Overage, L.P. DE 0.00 416494.00 0.00 416494.00 416494.00 0.6 PN The shares listed in rows 6, 8 and 9 consist of 416,494 shares of Common Stock held directly by Frazier Life Sciences Public Overage Fund, L.P. FHMLSP Overage, L.P. is the general partner of Frazier Life Sciences Public Overage Fund, L.P. and FHMLSP Overage, L.L.C. is the general partner of FHMLSP Overage, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP Overage, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Overage Fund, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. FHMLSP Overage, L.L.C. DE 0.00 416494.00 0.00 416494.00 416494.00 0.6 OO The shares listed in rows 6, 8 and 9 consist of 416,494 shares of Common Stock held directly by Frazier Life Sciences Public Overage Fund, L.P. FHMLSP Overage, L.P. is the general partner of Frazier Life Sciences Public Overage Fund, L.P. and FHMLSP Overage, L.L.C. is the general partner of FHMLSP Overage, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP Overage, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Overage Fund, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. Frazier Life Sciences X, L.P. DE 0.00 129479.00 0.00 129479.00 129479.00 0.2 PN The shares listed in rows 6, 8 and 9 consist of 129,479 shares of Common Stock held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. Patrick J. Heron and James N. Topper are the members of FHMLS X, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences X, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. FHMLS X, L.P. DE 0.00 129479.00 0.00 129479.00 129479.00 0.2 PN The shares listed in rows 6, 8 and 9 consist of 129,479 shares of Common Stock held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. Patrick J. Heron and James N. Topper are the members of FHMLS X, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences X, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. FHMLS X, L.L.C. DE 0.00 129479.00 0.00 129479.00 129479.00 0.2 OO The shares listed in rows 6, 8 and 9 consist of 129,479 shares of Common Stock held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. Patrick J. Heron and James N. Topper are the members of FHMLS X, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences X, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. Frazier Life Sciences XI, L.P. DE 0.00 258666.00 0.00 258666.00 258666.00 0.4 PN The shares listed in rows 6, 8 and 9 consist of 258,666 shares of Common Stock held directly by Frazier Life Sciences XI, L.P. FHMLS XI, L.P. is the general partner of by Frazier Life Sciences XI, L.P. and FHMLS XI, L.L.C. is the general partner of FHMLS XI, L.P. Patrick J. Heron, James N. Topper and Daniel Estes are the members of FHMLS XI, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences XI, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. FHMLS XI, L.P. DE 0.00 258666.00 0.00 258666.00 258666.00 0.4 PN The shares listed in rows 6, 8 and 9 consist of 258,666 shares of Common Stock held directly by Frazier Life Sciences XI, L.P. FHMLS XI, L.P. is the general partner of by Frazier Life Sciences XI, L.P. and FHMLS XI, L.L.C. is the general partner of FHMLS XI, L.P. Patrick J. Heron, James N. Topper and Daniel Estes are the members of FHMLS XI, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences XI, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. FHMLS XI, L.L.C. DE 0.00 258666.00 0.00 258666.00 258666.00 0.4 OO The shares listed in rows 6, 8 and 9 consist of 258,666 shares of Common Stock held directly by Frazier Life Sciences XI, L.P. FHMLS XI, L.P. is the general partner of by Frazier Life Sciences XI, L.P. and FHMLS XI, L.L.C. is the general partner of FHMLS XI, L.P. Patrick J. Heron, James N. Topper and Daniel Estes are the members of FHMLS XI, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences XI, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. James N. Topper X1 0.00 1410193.00 0.00 1410193.00 1410193.00 2.0 IN The shares listed in rows 6, 8 and 9 consist of (i) 605,554 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P., (ii) 416,494 shares of Common Stock held directly by Frazier Life Sciences Public Overage Fund, L.P., (iii) 129,479 shares of Common Stock held directly by Frazier Life Sciences X, L.P. and (iv) 258,666 shares of Common Stock held directly by Frazier Life Sciences XI, L.P. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. FHMLSP Overage, L.P. is the general partner of Frazier Life Sciences Public Overage Fund, L.P. and FHMLSP Overage, L.L.C. is the general partner of FHMLSP Overage, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP Overage, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Overage Fund, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. Patrick J. Heron and James N. Topper are the members of FHMLS X, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences X, L.P. FHMLS XI, L.P. is the general partner of by Frazier Life Sciences XI, L.P. and FHMLS XI, L.L.C. is the general partner of FHMLS XI, L.P. Patrick J. Heron, James N. Topper and Daniel Estes are the members of FHMLS XI, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences XI, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. Patrick J. Heron X1 0.00 1410193.00 0.00 1410193.00 1410193.00 2.0 IN The shares listed in rows 6, 8 and 9 consist of (i) 605,554 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P., (ii) 416,494 shares of Common Stock held directly by Frazier Life Sciences Public Overage Fund, L.P., (iii) 129,479 shares of Common Stock held directly by Frazier Life Sciences X, L.P. and (iv) 258,666 shares of Common Stock held directly by Frazier Life Sciences XI, L.P. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. FHMLSP Overage, L.P. is the general partner of Frazier Life Sciences Public Overage Fund, L.P. and FHMLSP Overage, L.L.C. is the general partner of FHMLSP Overage, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP Overage, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Overage Fund, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. Patrick J. Heron and James N. Topper are the members of FHMLS X, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences X, L.P. FHMLS XI, L.P. is the general partner of by Frazier Life Sciences XI, L.P. and FHMLS XI, L.L.C. is the general partner of FHMLS XI, L.P. Patrick J. Heron, James N. Topper and Daniel Estes are the members of FHMLS XI, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences XI, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. Albert Cha X1 0.00 1022048.00 0.00 1022048.00 1022048.00 1.4 IN The shares listed in rows 6, 8 and 9 consist of (i) 605,554 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P., and (ii) 416,494 shares of Common Stock held directly by Frazier Life Sciences Public Overage Fund, L.P. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. FHMLSP Overage, L.P. is the general partner of Frazier Life Sciences Public Overage Fund, L.P. and FHMLSP Overage, L.L.C. is the general partner of FHMLSP Overage, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP Overage, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Overage Fund, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. James Brush X1 0.00 1022048.00 0.00 1022048.00 1022048.00 1.4 IN The shares listed in rows 6, 8 and 9 consist of (i) 605,554 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P., and (ii) 416,494 shares of Common Stock held directly by Frazier Life Sciences Public Overage Fund, L.P. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. FHMLSP Overage, L.P. is the general partner of Frazier Life Sciences Public Overage Fund, L.P. and FHMLSP Overage, L.L.C. is the general partner of FHMLSP Overage, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP Overage, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Overage Fund, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. Daniel Estes X1 0.00 258666.00 0.00 258666.00 258666.00 0.4 IN The shares listed in rows 6, 8 and 9 consist of 258,666 shares of Common Stock held directly by Frazier Life Sciences XI, L.P. FHMLS XI, L.P. is the general partner of by Frazier Life Sciences XI, L.P. and FHMLS XI, L.L.C. is the general partner of FHMLS XI, L.P. Patrick J. Heron, James N. Topper and Daniel Estes are the members of FHMLS XI, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences XI, L.P. The percentage listed in row 11 is calculated based on 71,026,825 shares of Common Stock outstanding on February 4, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 18, 2025. ORIC Pharmaceuticals, Inc. 240 E. Grand Ave, 2nd Floor, South San Francisco, CA, 94080. The entities and persons filing this statement (collectively, the "Reporting Persons") are: Frazier Life Sciences Public Fund, L.P. ("FLSPF") FHMLSP, L.P. FHMLSP, L.L.C. Frazier Life Sciences Public Overage Fund, L.P. ("FLSPOF") FHMLSP Overage, L.P. FHMLSP Overage, L.L.C. Frazier Life Sciences X, L.P. ("FLS X") FHMLS X, L.P. FHMLS X, L.L.C. Frazier Life Sciences XI, L.P. ("FLS XI") FHMLS XI, L.P. FHMLS XI, L.L.C. James N. Topper ("Topper") Patrick J. Heron ("Heron") Albert Cha ("Cha") James Brush ("Brush") Daniel Estes ("Estes" and together with Topper, Heron, Cha and Brush, the "Members") The address of the principal place of business for each of the Reporting Persons is: c/o Frazier Life Sciences Management, L.P. 1001 Page Mill Rd, Building 4, Suite B Palo Alto, CA 94304 Entities: FLSPF - Delaware, U.S.A. FHMLSP, L.P. - Delaware, U.S.A. FHMLSP, L.L.C. - Delaware, U.S.A. FLSPOF - Delaware, U.S.A. FHMLSP Overage, L.P. - Delaware, U.S.A. FHMLSP Overage, L.L.C. - Delaware, U.S.A. FLS X - Delaware, U.S.A. FHMLS X, L.P. - Delaware, U.S.A. FHMLS X, L.L.C. - Delaware, U.S.A. FLS XI - Delaware, U.S.A. FHMLS XI, L.P. - Delaware, U.S.A. FHMLS XI, L.L.C. - Delaware, U.S.A. Individuals: Topper - United States Citizen Heron - United States Citizen Cha - United States Citizen Brush - United States Citizen Estes - United States Citizen Y The information contained in row 9 of each Reporting Person's cover page to this Schedule 13G (including the footnotes thereto) is incorporated by reference. The information contained in row 11 of each Reporting Person's cover page to this Schedule 13G (including the footnotes thereto) is incorporated by reference. The information contained in row 5 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference. The information contained in row 6 of each Reporting Person's cover page to this Schedule 13G (including the footnotes thereto) is incorporated by reference. The information contained in row 7 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference. The information contained in row 8 of each Reporting Person's cover page to this Schedule 13G (including the footnotes thereto) is incorporated by reference. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 99.1 Joint Filing Agreement. Frazier Life Sciences Public Fund, L.P. /s/ Steve R. Bailey 05/15/2025 FHMLSP, L.P. /s/ Steve R. Bailey 05/15/2025 FHMLSP, L.L.C. /s/ Steve R. Bailey 05/15/2025 Frazier Life Sciences Public Overage Fund, L.P. /s/ Steve R. Bailey 05/15/2025 FHMLSP Overage, L.P. /s/ Steve R. Bailey 05/15/2025 FHMLSP Overage, L.L.C. /s/ Steve R. Bailey 05/15/2025 Frazier Life Sciences X, L.P. /s/ Steve R. Bailey 05/15/2025 FHMLS X, L.P. /s/ Steve R. Bailey 05/15/2025 FHMLS X, L.L.C. /s/ Steve R. Bailey 05/15/2025 Frazier Life Sciences XI, L.P. /s/ Steve R. Bailey 05/15/2025 FHMLS XI, L.P. /s/ Steve R. Bailey 05/15/2025 FHMLS XI, L.L.C. /s/ Steve R. Bailey 05/15/2025 James N. Topper /s/ Steve R. Bailey 05/15/2025 Patrick J. Heron /s/ Steve R. Bailey 05/15/2025 Albert Cha /s/ Steve R. Bailey 05/15/2025 James Brush /s/ Steve R. Bailey 05/15/2025 Daniel Estes /s/ Steve R. Bailey 05/15/2025